when was semaglutide patented Patent expires next year: Novo Nordisk faces tough competition in the Chinese obesity market Novo Nordisk Settles Ozempic Patent

The unprecedented demand for glucagon-like peptide-1 (GLP-1) receptor agonists, specifically semaglutide and tirzepatide, has transformed what was once a niche practice of customized medication into a multi-billion-dollar shadow industry

If you found this article helpful, please share it with others who might benefit.

DNA methylation has been found to regulate the expression of the critical enzyme glutamine synthetase, resulting in the metabolic reprogramming of glutamine in tumor cells (73)

Studies have linked selenium deficiency with higher autoantibody titers in patients with HT, suggesting a potential immunomodulatory role (63)

Lets explore together